
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
TSPAN18 CRISPR/Cas9 KO Plasmid (h) | sc-405937 | 20 µg | $397.00 |
TSPAN18 encodes a tetraspanin family membrane protein that helps organize tetraspanin-enriched microdomains, coordinating lateral interactions among receptors, adhesion molecules, and signaling adaptors at the plasma membrane. Through these scaffolding functions, TSPAN18 can influence processes such as cell–cell communication, membrane trafficking, and signal integration that shape cellular activation and motility programs. Expression and genetic variation in tetraspanins, including TSPAN18, have been linked in the literature to platelet-related phenotypes and vascular biology, supporting use of this target in studies of hemostasis-associated signaling and inflammatory responses. Dissecting TSPAN18 function can clarify how membrane microdomain composition modulates downstream pathways relevant to cardiovascular and immune-associated disease mechanisms.
TSPAN18 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the TSPAN18 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the TSPAN18 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the TSPAN18 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish TSPAN18 protein expression.
This CRISPR knockout system enables efficient generation of TSPAN18-deficient cell models for investigation of TSPAN18 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.